Clinical trial
Optimising Hypertension Management: Real-World Effectiveness of Zestril Personalised Dosing With the OptiZ Software as a Medical Device Companion App
NCT06745726 is registered in ClinicalTrials.gov with Closed Loop Medicine as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Optimising Hypertension Management: Real-World Effectiveness of Zestril Personalised Dosing With the OptiZ Software as a Medical Device Companion App
- Lead sponsor
- Closed Loop Medicine
- Phase
- Observational
- Overall status
- Withdrawn
- Start date
- March 31, 2025
- Completion date
- October 31, 2026
- Enrollment
- 0 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.